Make a donation

Onchocerciasis in Africa and the fight to end it 

Imagen de Onchocerciasis in Africa and the fight to end it 

Onchocerciasis, commonly known as river blindness, is one of Africa’s most persistent neglected tropical diseases. It affects millions of people, particularly in remote rural areas. Coordinated global and local efforts have made significant progress in reducing its spread, but the fight is not yet over.

Whats river blindness is and how it spreads

River blindness is caused by the Onchocerca volvulus parasite. When blackflies bite a human host, they inject the larvae under the skin. These larvae mature into adult worms, which can live up to 15 years in the human body and produce thousands of microfilariae. These are tiny larvae that migrate to the skin and eyes.

As the immune system attacks the microfilariae, it leads to intense itching, swelling and inflammation, and over time, can cause permanent blindness. Since the disease affects people over many years, its full impact often goes unnoticed until it’s too late.

Onchocerciasis is still affecting millions in Africa

Over 99% of all cases of Onchocerciasis occur in Africa, where an estimated 20 million people are infected and millions more are at risk. The disease is especially prevalent in areas near fast-flowing rivers and streams, where blackflies breed and spread the parasite.

The symptoms go far beyond vision loss. Onchocerciasis causes severe skin irritation, changes in skin pigmentation (“leopard skin”), and disfigurement. Children often drop out of school, adults cannot work, and entire communities suffer economically and socially due to this debilitating disease.

How local and global program helps stop disease

Efforts to control and eliminate Onchocerciasis have been ongoing for decades. One of the most successful strategies has been the mass distribution of the drug ivermectin, donated by pharmaceutical company Merck under the Mectizan Donation Program. Ivermectin kills the microfilariae, relieves symptoms and prevents transmission when given annually or biannually. Community-directed treatment programs (CDTI) —where local volunteers deliver the medication— have proven cost-effective and sustainable.

Organizations such as the World Health Organization (WHO), African Programme for Onchocerciasis Control (APOC) and The END Fund have been instrumental in supporting national governments with logistics, training, and monitoring.

What is needed to eliminate it for good

While massive progress has been made, especially in West Africa, challenges remain in conflict zones, hard-to-reach regions, and areas with weak health infrastructure. To eliminate river blindness completely, steps as these are essential:

  • Sustained drug distribution. Ensure regular ivermectin coverage in all endemic areas.
  • Improved disease surveillance. Monitor transmission rates, even in low-risk zones.
  • Health system strengthening. Train health workers and volunteers to maintain coverage.
  • Community engagement. Build local trust and participation in treatment programs.
  • Research and innovation. Develop new tools and diagnostics for difficult cases.

With continued commitment and cross-sector cooperation, Onchocerciasis can be eliminated. The future generations can get rid the burden of river blindness if we act now. That’s our job. Do you want to join us? The end is in sight.

Share here:
Related content